Kit of Mycobacterium tuberculosis and detection method thereof
A technology for Mycobacterium tuberculosis and kits, applied in biochemical equipment and methods, microbial determination/inspection, analytical materials, etc., can solve the lack of detection methods, limitations of specificity and sensitivity, and long detection time, etc. problems, to achieve the effects of high detection sensitivity and precision, high sensitivity and specificity, and simple in vitro synthesis
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Publication Date
- 2011-06-01
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of infectious disease detection, and in particular relates to a kit for Mycobacterium tuberculosis. At the same time, the invention also relates to a kit for Mycobacterium tuberculosis to detect Mycobacterium tuberculosis. Mycobacterium, and Mycobacterium tuberculosis or bacterial antigens in sputum, blood and body fluids of suspected patients are applicable to all hospitals, including infectious disease and tuberculosis hospitals, for the detection of Mycobacterium tuberculosis. Background technique
[0002] Tuberculosis is a chronic consumptive infectious disease caused by Mycobacterium tuberculosis and zoonotic, which poses a serious threat to human health. According to the statistics of the World Health Organization (WHO), nearly one-third of the people in the world are currently infected with Mycobacterium tuberculosis, and there are 20 million active tuberculosis patients, 3 million people die of tuber...
Examples
Embodiment 1
[0033] A reagent kit for mycobacterium tuberculosis, comprising a 96-well ELISA plate, biotin-labeled nucleic acid aptamer NK2, horseradish peroxidase-labeled streptavidin and a chromogenic substrate. The preparation process is as follows:
[0034] 1. Synthesize the NK2 sequence and send the NK2 sequence to the company for synthesis. The 5' end of the biotin-labeled NK2 synthesized by the company is: bio-NK2. The sequence of the biotin-labeled nucleic acid adapter NK2 is shown in SEQ ID NO.1 the nucleotide sequence. And diluted with sterile double distilled water to the concentration of 100nM, 200nM, 400nM, stored in -20 ℃ refrigerator.
[0035] 2. Mycobacterium tuberculosis standard strain H37Rv (derived from ATCC 93009, Biochemical and Biophysical Research Communications 357 (2007) 743-748), BCG (derived from Biochemical and Biophysical Research Communications 357 (2007) 743-748), bird branch Bacillus M2 (M.avium, derived from ATCC25291, Clin Chem Lab Med.2009.47(4):405-11...
Embodiment 2
[0042] A method for detecting Mycobacterium tuberculosis with a kit for Mycobacterium tuberculosis, the specific process of kit detection:
[0043] 1. Take the sputum of different tuberculosis patients, the sputum of non-tuberculosis patients and normal people, and use this kit to test the samples of tuberculosis patients and other samples. The process is as follows:
[0044] In a 96-well ELISA plate, 100 μl of diluted sputum (1:10 diluted with normal saline) sample was added to each well, and a negative control well without sputum was set at the same time, incubated at 37° C. for 2 hours. Discard the liquid in the wells, add 300 μl PBST to each well, wash 4 times, then add 400 nM concentration of biotin-labeled aptamers, 100 μl per well, and incubate for 1 hour at 37°C. Discard the liquid in the wells, Add 300 μl PBST to the well, wash 4 times, then add horseradish peroxidase-labeled streptavidin, and incubate at 37°C for half an hour. Discard the liquid in the wells, add 30...